Home › Compare › Mounjaro vs Saxenda
Mounjaro vs Saxenda in South Africa
How Mounjaro (tirzepatide) and Saxenda (liraglutide) compare on cost, dosing and what they're approved for.
| Mounjaro | Saxenda | |
|---|---|---|
| Active ingredient | tirzepatide | liraglutide |
| How often | once weekly | once daily |
| Monthly cost | R2 800–R5 500 | R2 800–R5 400 |
| Approved for | Dual-action (GIP/GLP-1) for type 2 diabetes and weight management | Registered for weight management |
| Medical aid | Generally not covered for weight loss; diabetes use may qualify on application | Not typically covered for weight loss |
Mounjaro
The newer tirzepatide option, often cited for strong results. Distributed by Aspen in SA as single-dose vials (a KwikPen is under SAHPRA evaluation); a typical month is about R4 000 for four vials.
Mounjaro detailsSaxenda
The daily liraglutide pen — the longest-available weight-loss GLP-1 in SA, now often overtaken by weekly options. A 6 mg/mL pen is around R2 727, and a typical month works out near R4 600.
Saxenda detailsFrequently asked questions
Is Mounjaro or Saxenda better for weight loss?
What is the price difference between Mounjaro and Saxenda in South Africa?
Can I switch from Mounjaro to Saxenda?
Sources: South African Health Products Regulatory Authority (SAHPRA) registration data, the approved package inserts, and public pharmacy price listings. Last reviewed 2026-05-30. No information here is medical advice.